- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Hyperkalaemia
- Meeting Date: November 2020
- Public Summary Document (PSD) November 2020 PBAC Meeting - (PDF 1749KB)
- Public Summary Document (PSD) November 2020 PBAC Meeting - (Word 300KB)
Patiromer – November 2020
Patiromer: Sachet, 8.4 g powder for oral liquid; Sachet, 16.8 g powder for oral liquid; Veltassa®
Last updated
5 March 2021